In the last trading session, 4.26 million Tempest Therapeutics Inc (NASDAQ:TPST) shares changed hands as the company’s beta touched -1.84. With the company’s per share price at $1.10 changed hands at -$0.05 or -4.35% during last session, the market valuation stood at $27.73M. TPST’s last price was a discount, traded about -565.45% off its 52-week high of $7.32. The share price had its 52-week low at $0.92, which suggests the last value was 16.36% up since then. When we look at Tempest Therapeutics Inc’s average trading volume, we note the 10-day average is 12.43 million shares, with the 3-month average coming to 4.08 million.
Analysts gave the Tempest Therapeutics Inc (TPST) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended TPST as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Tempest Therapeutics Inc’s EPS for the current quarter is expected to be -0.36.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Tempest Therapeutics Inc (NASDAQ:TPST) trade information
Instantly TPST was in red as seen at the end of in last trading. With action 7.32%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -75.00%, with the 5-day performance at 7.32% in the green. However, in the 30-day time frame, Tempest Therapeutics Inc (NASDAQ:TPST) is -21.99% down. Looking at the short shares, we see there were 1.86 million shares sold at short interest cover period of 5.12 days.
Tempest Therapeutics Inc (TPST) estimates and forecasts
Data shows that the Tempest Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -64.52% over the past 6 months, a 21.47% in annual growth rate that is considerably higher than the industry average of 17.50%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 62.66%. The 2024 estimates are for Tempest Therapeutics Inc earnings to increase by 22.35%.
TPST Dividends
Tempest Therapeutics Inc is expected to release its next quarterly earnings report on 2024-Nov-06.
Tempest Therapeutics Inc (NASDAQ:TPST)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.24% of Tempest Therapeutics Inc shares while 22.43% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 22.49%. There are 22.43% institutions holding the Tempest Therapeutics Inc stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 2.4747% of the shares, roughly 0.55 million TPST shares worth $1.21 million.
FMR LLC holds the second largest percentage of outstanding shares, with 1.9426% or 0.43 million shares worth $0.95 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jun 30, 2024 were Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund . With 174.01 shares estimated at $0.19 million under it, the former controlled 0.69% of total outstanding shares. On the other hand, Fidelity Extended Market Index Fund held about 0.35% of the shares, roughly 88.36 shares worth around $97199.0.
